MedTrace Logo

Clinical Investigation of the Cheetah System For The Correction of Myopia With and Without Astigmatism

NCT04200898 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 286

Last updated 2025-12-22

No results posted yet for this study

Summary

This study will be a 3-phase, 12-months, prospective,single arm, multicenter, open-label, non-comparative, clinical investigation conducted at up to 7 sites. Up to 20 subjects will be enrolled in phase I, up to 30 subjects in phase II, and up to 200 subjects in phase 3 to achieve up to 350 treated eyes.

Conditions

  • Myopia
  • Astigmatism

Interventions

DEVICE

Cheetah System

For each subject, surgeons will create an iLEX refractive correction using the investigational Cheetah femtosecond laser (Models Cheetah Beta 2a, Cheetah Production Equivalent \[ELITA\]) and Cheetah patient interface (regular or small diameter designs).

Sponsors & Collaborators

  • Johnson & Johnson Surgical Vision, Inc.

    lead INDUSTRY

Principal Investigators

  • Johnson & Johnson Surgical Vision Clinical Trials · Johnson & Johnson Surgical Vision

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SEQUENTIAL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-12-31
Primary Completion
2024-12-06
Completion
2024-12-06
FDA Device
Yes

Countries

  • Croatia
  • India
  • Italy
  • Singapore

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04200898 on ClinicalTrials.gov